Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  32,389 results for ""DOXAZOSIN""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Change in prostate tissue gene expression following finasteride or doxazosin administration in the medical therapy for prostatic symptoms (MTOPS) study.

  • Authors : Choi HY; Department of Preventive Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.; UTHSC Center for Cancer Research, University of Tennessee Health Science Center, Memphis, TN, USA.

Subjects: Prostate*/Prostate*/Prostate*/metabolism ; Finasteride*/Finasteride*/Finasteride*/pharmacology ; Finasteride*/Finasteride*/Finasteride*/therapeutic use

  • Source: Scientific reports [Sci Rep] 2024 Aug 19; Vol. 14 (1), pp. 19164. Date of Electronic Publication: 2024 Aug 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The combination of doxazosin and metyrosine as a preoperative treatment for pheochromocytomas and paragangliomas.

  • Authors : Ohmachi Y; Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.; Yamamoto M

Subjects: Doxazosin*/Doxazosin*/Doxazosin*/therapeutic use ; Doxazosin*/Doxazosin*/Doxazosin*/administration & dosage ; Pheochromocytoma*/Pheochromocytoma*/Pheochromocytoma*/surgery

  • Source: Endocrine [Endocrine] 2024 May; Vol. 84 (2), pp. 694-703. Date of Electronic Publication: 2024 Jan 11.Publisher: Humana Press Country of Publication: United States NLM ID: 9434444 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The α-1 Adrenergic Receptor Antagonist Doxazosin Attenuates Liver Fibrosis by Alleviating Sinusoidal Capillarization and Liver Angiogenesis.

  • Authors : Xiu AY; Department of Gastroenterology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250021, China.; Ding Q

Subjects: Doxazosin*/Doxazosin*/Doxazosin*/pharmacology ; Doxazosin*/Doxazosin*/Doxazosin*/therapeutic use ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/drug therapy

  • Source: Advanced biology [Adv Biol (Weinh)] 2024 Jun; Vol. 8 (6), pp. e2300513. Date of Electronic Publication: 2024 Mar 17.Publisher: Wiley-VCH GmbH Country of Publication: Germany NLM ID: 101775319 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Association of Terazosin, Doxazosin, or Alfuzosin Use and Risk of Dementia With Lewy Bodies in Men.

  • Authors : Hart A; From the Department of Neurology (A.H.), University of Michigan, Ann Arbor; Departments of Neurology (G.A., Q.Z., N.S.N.) and Internal Medicine (J.E.S.), University of Iowa, Iowa City.

Subjects: Doxazosin*/Doxazosin*/Doxazosin*/therapeutic use ; Prazosin*/Prazosin*/Prazosin*/analogs & derivatives ; Prazosin*/Prazosin*/Prazosin*/therapeutic use

  • Source: Neurology [Neurology] 2024 Jul 23; Vol. 103 (2), pp. e209570. Date of Electronic Publication: 2024 Jun 19.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR.

  • Authors : Kim S; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul, 02841, Republic of Korea.; Brain Korea 21 Program for Biomedical Science, Korea University College of Medicine, Korea University, Seoul, 02841, Republic of Korea.

Subjects: Doxazosin*/Doxazosin*/Doxazosin*/pharmacology ; Doxazosin*/Doxazosin*/Doxazosin*/therapeutic use ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Nov 04; Vol. 42 (1), pp. 292. Date of Electronic Publication: 2023 Nov 04.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

Record details

Read More Add to Saved list
×
Academic Journal

Effect of different alpha-receptor antagonists on metabolic parameters: a head-to-head comparison.

  • Authors : Caştur L; Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital Department of İnternal Medicine, Istanbul, Turkey.; Uzunlulu M

Subjects: Doxazosin*/Doxazosin*/Doxazosin*/therapeutic use ; Tamsulosin*/Tamsulosin*/Tamsulosin*/therapeutic use ; Adrenergic alpha-1 Receptor Antagonists*/Adrenergic alpha-1 Receptor Antagonists*/Adrenergic alpha-1 Receptor Antagonists*/therapeutic use

  • Source: International urology and nephrology [Int Urol Nephrol] 2024 Aug; Vol. 56 (8), pp. 2489-2494. Date of Electronic Publication: 2024 Mar 08.Publisher: Springer Country of Publication: Netherlands NLM ID: 0262521 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Identifying mitigating strategies for endothelial cell dysfunction and hypertension in response to VEGF receptor inhibitors.

  • Authors : Camarda ND; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, U.S.A.; Genetics, Molecular, and Cellular Biology Program, Tufts Graduate School of Biomedical Sciences, Boston, MA, U.S.A.

Subjects: Hypertension*/Hypertension*/Hypertension*/drug therapy ; Hypertension*/Hypertension*/Hypertension*/metabolism ; Hypertension*/Hypertension*/Hypertension*/physiopathology

  • Source: Clinical science (London, England : 1979) [Clin Sci (Lond)] 2024 Sep 18; Vol. 138 (18), pp. 1131-1150.Publisher: Portland Press on behalf of the Medical Research Society and the Biochemical Society Country of Publication: England NLM ID: 7905731 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Unexpected bradycardia after a first dose of doxazosin.

  • Authors : Pigot JE; General Medicine, Maidstone and Tunbridge Wells NHS Trust, Maidstone, UK .; Szeto MCH

Subjects: Doxazosin*/Doxazosin*/Doxazosin*/adverse effects ; Hypertension*/Hypertension*/Hypertension*/drug therapy; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/therapeutic use

  • Source: Postgraduate medical journal [Postgrad Med J] 2022 Jul; Vol. 98 (1161), pp. e17. Date of Electronic Publication: 2021 Feb 05.Publisher: Oxford University Press Country of Publication: England NLM ID: 0234135 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ERα and Wnt/β-catenin signaling pathways.

  • Authors : Karaca B; Hakan Çetinsaya Good Clinical Practice and Research Center, Erciyes University, Kayseri, Turkey.; Bakır E

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Doxazosin/Doxazosin/Doxazosin/*therapeutic use ; Endometrial Neoplasms/Endometrial Neoplasms/Endometrial Neoplasms/*drug therapy

  • Source: Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2021 Nov; Vol. 35 (11), pp. e22905. Date of Electronic Publication: 2021 Aug 30.Publisher: Wiley Country of Publication: United States NLM ID: 9717231 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-0461

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and tolerability of doxazosin gastro-intestinal therapeutic system versus tamsulosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: A systematic review and meta-analysis.

  • Authors : Guo J; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.; Tang R

Subjects: Doxazosin/Doxazosin/Doxazosin/*therapeutic use ; Lower Urinary Tract Symptoms/Lower Urinary Tract Symptoms/Lower Urinary Tract Symptoms/*drug therapy ; Prostatic Hyperplasia/Prostatic Hyperplasia/Prostatic Hyperplasia/*complications

  • Source: Medicine [Medicine (Baltimore)] 2021 Aug 20; Vol. 100 (33), pp. e26955.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  32,389 results for ""DOXAZOSIN""